US Equity
MNKD
— MANNKIND CORPORATIONMannKind Corporation is a biopharmaceutical company that develops and commercializes inhaled therapeutic products, including Afrezza for diabetes management.
💰 Market cap: $1.22B📍 1 Casper Street, DANBURY, CT, 06810 US🏷️ Biotechnology & Medical Research💵 Previous close: $4.13🔢 5,676 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $4.13 |
| 2026-07-23 | $3.89 |
| 2026-07-22 | $3.84 |
| 2026-07-21 | $4.05 |
| 2026-07-20 | $3.98 |
| 2026-07-17 | $4.03 |
| 2026-07-16 | $4.04 |
| 2026-07-15 | $4.09 |
| 2026-07-14 | $3.88 |
| 2026-07-13 | $4.04 |
| 2026-07-10 | $4.09 |
| 2026-07-09 | $4.14 |
| 2026-07-08 | $4.25 |
| 2026-07-07 | $4.22 |
| 2026-07-06 | $4.27 |
| 2026-07-02 | $4.52 |
| 2026-07-01 | $4.05 |
| 2026-06-30 | $4.26 |
| 2026-06-29 | $4.24 |
| 2026-06-26 | $4.14 |
| 2026-06-25 | $3.93 |
| 2026-06-24 | $3.84 |
| 2026-06-23 | $3.93 |
| 2026-06-22 | $3.89 |
| 2026-06-18 | $3.94 |
| 2026-06-17 | $3.92 |
| 2026-06-16 | $3.87 |
| 2026-06-15 | $4.00 |
| 2026-06-12 | $3.66 |
| 2026-06-11 | $3.75 |
| 2026-06-10 | $3.63 |
| 2026-06-09 | $3.57 |
| 2026-06-08 | $3.39 |
| 2026-06-05 | $3.40 |
| 2026-06-04 | $3.52 |
| 2026-06-03 | $3.36 |
| 2026-06-02 | $3.43 |
| 2026-06-01 | $3.53 |
| 2026-05-29 | $3.77 |
| 2026-05-28 | $3.64 |
| 2026-05-27 | $3.55 |
| 2026-05-26 | $3.53 |
| 2026-05-22 | $3.38 |
| 2026-05-21 | $3.31 |
| 2026-05-20 | $3.25 |
| 2026-05-19 | $2.96 |
| 2026-05-18 | $2.99 |
| 2026-05-15 | $3.09 |
| 2026-05-14 | $3.22 |
| 2026-05-13 | $3.21 |
| 2026-05-12 | $3.28 |
| 2026-05-11 | $3.36 |
| 2026-05-08 | $3.52 |
| 2026-05-07 | $3.55 |
| 2026-05-06 | $3.56 |
| 2026-05-05 | $2.86 |
| 2026-05-04 | $2.81 |
| 2026-05-01 | $2.84 |
| 2026-04-30 | $2.83 |
| 2026-04-29 | $2.75 |
| 2026-04-28 | $2.79 |